Related Experiment Videos
[Advance in the research of endostatin]
1Beijing Institute of Biotechnology, Key Lab. of Molecule Genetics, Beijing 100850, China. fefeicat@mailcity.com
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology
|January 19, 2002
Abstract:
Endostatin was a newly found N-terminal fragment of collagen XVIII NC1 domain, which has distinct anti-angiogenesis character. Its prominent anti-tumor effect in mouse model made its a hot point of research and a promising anti-tumor drug candidate. This article will give some discussion in this field.
Insights
Endostatin, an N-terminal fragment of collagen XVIII, exhibits significant anti-angiogenesis properties. Its demonstrated anti-tumor effects in mouse models highlight its potential as a promising therapeutic candidate for cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Context:
- Endostatin is a novel N-terminal fragment derived from the collagen XVIII NC1 domain.
- This fragment possesses distinct anti-angiogenic characteristics.
Purpose:
- To discuss the anti-tumor potential of endostatin.
- To explore endostatin's role in cancer research.
Summary:
- Endostatin, derived from collagen XVIII, shows potent anti-angiogenesis activity.
- Preclinical studies in mouse models indicate significant anti-tumor effects.
Impact:
- Endostatin represents a promising candidate for novel anti-cancer drug development.
- Further research into endostatin could lead to new therapeutic strategies for various cancers.